Product
Allogeneic Stem Cell Transplant
1 clinical trial
1 indication
Indication
Hematologic DisordersClinical trial
Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-partially Matched Related or Unrelated Donor After TCR αβ+T Cells/CD19+ B Cell Depletion in Children and Young Adults Affected by Malignant or Non-Malignant Hematological DisordersStatus: Recruiting, Estimated PCD: 2025-02-01